Efficacy and safety of the fixed oral perindopril arginine 5mg/amlodipine 5mg combination compared with amlodipine 5mg alone in patients not adequately controlled with amlodipine 5mg monotherapy. A randomised double blind 12 weeks study with up titration after 8 weeks in non controlled patients.

Trial Profile

Efficacy and safety of the fixed oral perindopril arginine 5mg/amlodipine 5mg combination compared with amlodipine 5mg alone in patients not adequately controlled with amlodipine 5mg monotherapy. A randomised double blind 12 weeks study with up titration after 8 weeks in non controlled patients.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Jan 2016

At a glance

  • Drugs Perindopril/amlodipine (Primary) ; Amlodipine
  • Indications Essential hypertension
  • Focus Registrational; Therapeutic Use
  • Sponsors IRIS
  • Most Recent Events

    • 21 May 2012 Actual end date 13 Jun 2011 added as reported by Chinese Clinical Trial Register.
    • 25 Feb 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top